• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Glytec garners cybersecurity certification for insulin management system

January 4, 2022 By Sean Whooley

GlytecGlytec announced today that its eGlycemic Management System received certified status for information security from HITRUST.

Waltham, Massachusetts-based Glytec’s certification validates its platform’s ability to meet the highest standards for protecting sensitive data and information when working with its health system customers.

According to a news release, HITRUST CSF certified status means the eGlycemic Management System (eGMS), including Glucommander, met key regulations and industry-defined requirements as it appropriately manages risk. HITRUST CSF aims to address challenges through a flexible framework of prescriptive and scalable security controls.

Glytec designed its eGMS with the FDA-cleared Glucommander algorithm, which uses real-time and historical data to recommend insulin dosing by learning each patient’s insulin sensitivity and anticipating future needs. The system provides a personalized treatment regime that can reduce hypoglycemia, hyperglycemia, lengths of stay, readmissions and cost of care.

“Hospitals across the country are facing increased cyber threats that can put patient information at risk, cause brand damage and violate HIPAA. Healthcare organizations must be able to trust that a technology partner’s platform is secure and compliant,” Glytec CTO Nausheen Moulana said in the release. “Achieving HITRUST CSF status is a testament to Glytec’s commitment to meet the privacy needs of our hospital partners, and to provide the most secure platform for the clinicians we serve and their patients.”

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Cybersecurity, Glytec

IN CASE YOU MISSED IT

  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance
  • Medtronic moves to divest final stake in MiniMed
  • Dexcom adds former Stryker CFO to board

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS